Human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and other viruses remain occupational risks for both surgeons and patients in the operating room environment. In the past, this concern attracted great attention, but recently, this subject has been given much less attention.
Methods:
Review of the literature over the past 50 years on occupational risks of viral infection in the operating room.
Results:
Transmission of HIV still looms as a potential pathogen in the operating room, but no case has been documented in the United States. Infection with HBV can be prevented by a safe and effective vaccine. Chronic HCV infection is present in more than three million U.S. residents and remains a risk that can be managed only by adhering to strict infection control practices and avoiding blood exposure.
Conclusions:
The risks of viral infection in the operating room remain the same as a decade ago even though attention to this issue has waned. The avoidance of blood exposure to prevent transmission of both known and unknown blood-borne pathogens continues to be a goal for all surgeons.
Get full access to this article
View all access options for this article.
References
1.
FaheyJB, KoziolED, BanksMS, HendersonKD. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am J Med, 1991; 90:145–153.
2.
U.S. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood—France, United Kingdom, and United States, January 1988–August 1994. MMWR Morbid Mortal Wkly Rep, 1995; 44:929–933.
3.
DoNA, CiesielskiAC, MetlerPRet al.Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol, 2003; 24:86–96.
4.
LotF, SeguierJC, FegueuxSet al.Probable Transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med, 1999; 130:1–6.
5.
U.S. Centers for Disease Control and Prevention. Update: Transmission of HIV infection during an invasive dental procedure–Florida. MMWR Morbid Mortal Wkly Rep, 1991; 40,RR-2:21–2733.
6.
ThompsonND, NovakRT, DattaDet al.Hepatitis C virus transmission in hemodialysis units: Importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol, 2009; 30:900–903.
7.
LessaF, TakS, DevaderSRet al.Risk of infections associated with improperly reprocessed transrectal ultrasound-guided prostate biopsy equipment. Infect Control Hosp Epidemiol, 2008; 29:289–293.
8.
GermainJM, CarbonneA, ThiersVet al.Patient-to-patient transmission of hepatitis C virus through the use of multidose vials during general anesthesia. Infect Control Hosp Epidemiol, 2005; 26:789–792.
9.
U.S. Centers for Disease Control and Prevention. Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopic clinic–Nevada, 2007. MMWR Morb Mortal Wkly Rep, 2008; 57:513–517.
10.
TrumbellML, GreinerDJ. Homologous serum jaundice: An occupational hazard to medical personnel. JAMA, 1951; 145:965–967.
11.
KuhC, WardWE. Occupational virus hepatitis: An apparent hazard for medical personnel. JAMA, 1950; 143:631–635.
12.
U.S. Centers for Disease Control and Prevention. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers—a response to P.I. 100–607. The Health Omnibus Program Extension Act of 1988. MMWR Morbid Mortal Wkly Rep, 1989; 38,S-6:3–37.
13.
FryDE. The ABCs of hepatitis. Adv Surg, 1999; 33:413–437.
14.
GottliebMS, SchroffR, SchankerHMet al.Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med, 1981; 305:1431.
15.
ChooQ-L, KuoG, WeinerAJet al.Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 1989; 244:359–362.
16.
Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR Morb Mortal Wkly Rep, 1991; 40,RR-8:1–9.
17.
Public Health and Welfare Act, 42 USC §300ee-2. 1994.
18.
Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens: Final rule. Fed Reg, 1991; 56:64175.
U.S. Centers for Disease Control and Prevention. Surveillance of occupationally acquired HIV/AIDS in healthcare personnel since 2006. www.cdc.gov/ncidod/dhqp/bp_hcp_w_hiv.html
25.
RobertLM, ChamberlandME, ClevelandJLet al.Investigation of patients of health care workers infected with HIV. Centers for Disease Control and Prevention database. Ann Intern Med, 1995; 122:653–657.
26.
TokarsJI, ChamberlandME, SchableCAet al.A survey of occupational blood contact and human immunodeficiency virus infection among orthopedic surgeons. The American Academy of Orthopaedic Surgeons Serosurvey Study Committee. JAMA, 1992; 268:489–494.
27.
BellDM. Occupational risk of human immunodeficiency virus infection in health-care workers: An overview. Am J Med, 1997; 102,5B:9–15.
28.
U.S. Centers for Disease Control and Prevention. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep, 1998; 47,No. RR-7:1–33.
29.
PanlilioAL, CardoDM, GrohskopfLAet al.Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep, 2005; 54,RR09:1–17.
30.
LeeWM. Hepatitis B virus infection. N Engl J Med, 1997; 337:1733–1745.
31.
ShapiroCN, TokarsJI, ChamberlandME. American Academy of Orthopaedic Surgeons Serosurvey Study Committee: Use of hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. J Bone Joint Surg, 1996; 78A:1791–1800.
32.
ShapiroCN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am, 1995; 75:1047–1056.
33.
HeptonstallJ. Outbreaks of hepatitis B virus infection associated with infected surgical staff. CDR Weekly, 1991; 1:R81–R85.
34.
HarpazR, von SeidleinL, AverhoffFMet al.Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med, 1996; 334:549–554.
35.
SpijkermanIJB, van DoornL-J, JansssenMHWet al.Transmission of hepatitis B virus from a surgeon to his patients during high-risk and low-risk surgical procedures during 4 years. Infect Control Hosp Epidemiol, 2002; 23:306–312.
36.
ZajacBA, WestDJ, McAleerWJ, ScolnickEM. Overview of clinical studies with hepatitis B vaccine made with recombinant DNA. J Infect Dis, 1986; 13,Suppl:39–45.
37.
HadlerSC, FrancisDP, MaynardJEet al.Long term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med, 1986; 315:209–214.
38.
HalpernSD, AschDA, ShakedAet al.Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: Prevalence, correlates, and implications. Ann Surg, 2006; 244:305–309.
39.
U.S. Centers for Disease Control and Prevention. Updated U.S. public health service guidelines for the management of occupational exposure to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep, 2001; 50:1–42.
40.
SheppardCW, FinelliL, AlterMJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis, 2005; 5:558–567.
41.
HowardRJ, FryDE, DavisJMet al.Hepatitis C virus infection in healthcare workers. J Am Coll Surg, 1997; 184:540–552.
42.
U.S. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus infection and HCV-related chronic disease. MMWR Morbid Mortal Wkly Rep, 1998; 47:1–39.
43.
KrawczynskiK, AlterMJ, TankersleyDLet al.Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis, 1996; 173:822–828.
44.
AlterMJ. Occupational exposure to hepatitis C virus: A dilemma. Infect Control Hosp Epidemiol, 1994; 15:742–744.
45.
U.S. Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Morbid Mortal Wkly Rep, 2001; 50,RR11:1–42.
46.
EstebanJI, GomezJ, MartellMet al.Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med, 1996; 334:555–560.
47.
DuckworthGJ, HeptonstallJ, AitkenC. Transmission of hepatitis C virus from a surgeon to a patient: The incident control team. Commun Dis Public Health, 1999; 2:188–192.
48.
RossRS, ViazovS, ThromahlenMet al.Risk of hepatitis C virus transmission from an infected gynecologist to patients: Results of a 7-year retrospective investigation. Arch Intern Med, 2002; 162:805–810.
49.
RossRS, ViazovS, RoggendorfM. Phylogenetic analysis indicates transmission of hepatitis C virus from an infected orthopaedic surgeon to a patient. J Med Virol, 2002; 66:461–467.
TokarsIJ, CulverHD, MendelsonHMet al.Skin and mucous membrane contacts with blood during surgical procedures: Risk and prevention. Infect Control Hosp Epidemiol, 2003; 16:703–711.
55.
PopejoySL, FryDE. Blood contact and exposure in the operating room. Surg Gynecol Obstet, 1991; 172:480–483.
56.
MattaH, ThompsonAM, RaineyJB. Does wearing two pairs of gloves protect operating theatre staff from skin contamination?Br Med J, 1988; 297:597–598.
57.
QuebbemanEJ, TelfordGJ, WadsworthKet al.Double gloving: Protecting surgeons from blood contamination in the operating room. Arch Surg, 1992; 127:213–217.
BerguerR, HellerPJ. Preventing sharps injuries in the operating room. J Am Coll Surg, 2004; 199:462–467.
62.
MakaryMA, PronovostPJ, WeissESet al.Sharpless surgery: A prospective study of the feasibility of performing operations using non-sharp techniques in an urban, university-based surgical practice. World J Surg, 2006; 30:1224–1229.
63.
Narayanan MenonKV. Non-A to E hepatitis. Curr Opin Infect Dis, 2002; 15:529–534.
64.
AlterHJ. Emerging, re-emerging and submerging infectious threats to the blood supply. Vox Sang, 2004; 87,Suppl 2:S56–S61.
